Shagun Bindlish
St. Peter’s Health Partners, USA
Title: Update on Gestational Diabetes- Diagnosis to delivery and beyond
Biography
Biography: Shagun Bindlish
Abstract
Pregnancy is a state of insulin resistance and hyperinsulinemia that may predispose some women to develop diabetes. Gestational diabetes mellitus (GDM) occurs when a woman’s pancreatic function is not able to overcome the diabetogenic environment of pregnancy. GDM is defined as a glucose intolerance that occurs during second or third trimester of pregnancy and is not clearly overt diabetes. The effectiveness and time period of screening and diagnosis of GDM has been controversial. There are conflicting recommendations from experts of multiple organizations suggesting to follow one step or two step approaches for the diagnosis. This talk will focus on discussing the latest diagnostic screening options, the treatment strategies for women with gestational diabetes and potential impact of diabetes on the mother during postpartum period. The discussion will include the focus group study to evaluate the effectiveness of postpartum screening time period. Our practice is using a novel approach incorporating data for diabetes prevention to find the effectiveness of postpartum screening that could best prevent or delay the onset of Type 2 diabetes in high risk population. Most updated literature will be collected using different resources including PubMed, American Diabetes Association, American College of Obstetrics and Gynecology and American society of Endocrinology.
